Autopsy report · NCT00174291

Prevention of Growth Retardation by Early Treatment With Growth Hormone (GH) in Children With CJA Treated by Corticosteroid Therapy

Cause of deathNo reason given Automatic label, confidence 0.9, unverified. How labels are made.

“See termination reason in detailed description.”

The sponsor’s own words in the registry.

Life of this trial

Registered 3 years 6 months after it had already started.
Ran for about 9 years 7 months before it stopped.
21 participants enrolled.
Results were posted on the registry 1 year 2 months after it ended.

Vital statistics

Status: Terminated
Phase: Phase 3
Sponsor: Pfizer
Sponsor type: Industry
Conditions: Endocrine System Diseases
Interventions: Somatropin
Participants: 21
Sites: 1
Countries: France

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.